Cleared Traditional

K771834 - CREATININE

K771834 is the FDA 510(k) clearance for CREATININE by Gamma Enterprises, Inc.. It is a Class 2 Chemistry device (product code CGX) cleared through the Traditional 510(k) pathway after a 43-day FDA review.

K771834 · Gamma Enterprises, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1977
Decision
43d
Days
Class 2
Risk

K771834 is an FDA 510(k) clearance for the CREATININE. Classified as Alkaline Picrate, Colorimetry, Creatinine (product code CGX), Class II - Special Controls.

Submitted by Gamma Enterprises, Inc. (Mchenry, US). The FDA issued a Cleared decision on November 3, 1977 after a review of 43 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Gamma Enterprises, Inc. devices

Submission Details

510(k) Number K771834 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 1977
Decision Date November 03, 1977
Days to Decision 43 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 88d · This submission: 43d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGX Alkaline Picrate, Colorimetry, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGX Alkaline Picrate, Colorimetry, Creatinine

All 117
Devices cleared under the same product code (CGX) and FDA review panel - the closest regulatory comparables to K771834.
ULTRACHEM CREATININE 64972, CENTRIFUCHEM
K780514 · Harleco · May 1978
CREATININE, 64972
K772157 · Harleco · Dec 1977
CREATININE URINE APPLI.-#32308
K772107 · Harleco · Nov 1977
DIR. QUANT. COLOR. DETERM. SERUM CREAT.
K771856 · Stanbio Laboratory · Nov 1977
PROCEDURE NO. 555
K771916 · Sigma Chemical Co. · Oct 1977
CLINICARD CREATININE CHEMISTRY
K771773 · Harleco · Oct 1977